379 related articles for article (PubMed ID: 18980046)
1. Advances in the treatment of acne.
Kimball AB
J Reprod Med; 2008 Sep; 53(9 Suppl):742-52. PubMed ID: 18980046
[TBL] [Abstract][Full Text] [Related]
2. YAZ and the novel progestin drospirenone.
Mishell DR
J Reprod Med; 2008 Sep; 53(9 Suppl):721-8. PubMed ID: 18980044
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
[TBL] [Abstract][Full Text] [Related]
4. Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.
Koltun W; Maloney JM; Marr J; Kunz M
Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):171-5. PubMed ID: 21288628
[TBL] [Abstract][Full Text] [Related]
5. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
van Vloten WA; van Haselen CW; van Zuuren EJ; Gerlinger C; Heithecker R
Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
[TBL] [Abstract][Full Text] [Related]
6. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
7. Hormonal contraceptives for acne management.
Rich P
Cutis; 2008 Jan; 81(1 Suppl):13-8. PubMed ID: 18338653
[TBL] [Abstract][Full Text] [Related]
8. Should dermatologists prescribe hormonal contraceptives for acne?
Harper JC
Dermatol Ther; 2009; 22(5):452-7. PubMed ID: 19845722
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives in the treatment of acne.
Tan JK; Degreef H
Skin Therapy Lett; 2001 Feb; 6(5):1-3. PubMed ID: 11242137
[TBL] [Abstract][Full Text] [Related]
10. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Dickerson V
J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial.
Koltun W; Lucky AW; Thiboutot D; Niknian M; Sampson-Landers C; Korner P; Marr J
Contraception; 2008 Apr; 77(4):249-56. PubMed ID: 18342647
[TBL] [Abstract][Full Text] [Related]
12. [Extracontraceptive benefits of EE/DRSP (Yaz) in 24+4 day regimen].
Bruni Bresciani V
Minerva Ginecol; 2010 Jun; 62(3):261-6. PubMed ID: 20595950
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Krunic A; Ciurea A; Scheman A
J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
[TBL] [Abstract][Full Text] [Related]
15. Acne vulgaris: recent advances in pathogenesis and treatment.
Caro I
J Fam Pract; 1977 Nov; 5(5):747-50. PubMed ID: 144774
[TBL] [Abstract][Full Text] [Related]
16. Hormonal therapy for acne using oral contraceptive pills.
Harper JC
Semin Cutan Med Surg; 2005 Jun; 24(2):103-6. PubMed ID: 16092798
[TBL] [Abstract][Full Text] [Related]
17. An oral contraceptive with 3 approved indications.
Mishell DR
J Reprod Med; 2008 Sep; 53(9 Suppl):717-9. PubMed ID: 18980043
[No Abstract] [Full Text] [Related]
18. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
Fenton C; Wellington K; Moen MD; Robinson DM
Drugs; 2007; 67(12):1749-65. PubMed ID: 17683173
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications.
Clarke SB; Nelson AM; George RE; Thiboutot DM
Dermatol Clin; 2007 Apr; 25(2):137-46, v. PubMed ID: 17430751
[TBL] [Abstract][Full Text] [Related]
20. Evolution of progestins. Focus on the novel progestin drospirenone.
Thorneycroft IH
J Reprod Med; 2002 Nov; 47(11 Suppl):975-80. PubMed ID: 12497671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]